Medicenna Therapeutics Corp. Reports Earnings Results for the Full Year Ended March 31, 2025

Published: 2025-06-26 16:53:22 ET MDNA.TO

Published on 06/26/2025 at 16:53

Medicenna Therapeutics Corp. reported earnings results for the full year ended March 31, 2025. For the full year, the company reported net loss was CAD 11.81 million compared to CAD 25.47 million a year ago.

Basic loss per share from continuing operations was CAD 0.15 compared to CAD 0.37 a year ago.